North America Point-Of-Care Infectious Disease Diagnostics Market was valued at USD 0.7 Billion in 2022 and is projected to reach USD 1.2 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030.
The North American point-of-care (POC) infectious disease diagnostics market has rapidly evolved, driven by the increasing need for fast, accurate, and easily accessible diagnostic tools. As healthcare systems face rising pressures to provide timely diagnosis and treatment, industries are increasingly turning to POC diagnostics to meet patient needs while minimizing delays and costs. The rise of chronic diseases, an aging population, and the North America threat of pandemics are all contributing factors to the demand for innovative diagnostic solutions. In particular, advancements in molecular diagnostics, immunoassays, and microfluidics have opened new opportunities for POC technologies in detecting infectious diseases.
One of the key applications of POC diagnostics is in managing infections like COVID-19, influenza, and respiratory diseases, where rapid results can be critical for treatment plans. The convenience of performing tests at the point of care—whether in a doctor's office, clinic, or even at home—has made these diagnostics highly valuable to both healthcare providers and patients alike. POC diagnostic tools offer immediate results, providing clinicians with the ability to make quicker decisions, which can ultimately improve patient outcomes and reduce healthcare costs.
Industries, such as healthcare providers, pharmaceutical companies, and diagnostics manufacturers, are investing in innovative technologies that enable quicker, more efficient testing. Companies are focusing on the development of user-friendly devices, which allow non-specialist personnel to carry out tests easily. Moreover, regulatory agencies are also supporting the adoption of POC diagnostics by easing approval processes, paving the way for faster market entry of new diagnostic tools.
The need for faster diagnostics is critical in various industrial sectors, ranging from hospitals and clinics to home healthcare providers. Healthcare professionals are demanding systems that provide reliable, quick, and easy-to-use diagnostics to support better clinical decisions. As such, there is a growing shift towards enhancing the accessibility of infectious disease testing through decentralized healthcare delivery models, such as telemedicine and mobile diagnostics, especially in rural or underserved areas.
As the North American point-of-care infectious disease diagnostics market continues to expand, the shift towards rapid, accessible, and cost-effective diagnostic solutions will undoubtedly shape the future of healthcare delivery.
North America Point-Of-Care Infectious Disease Diagnostics Market
Get an In-Depth Research Analysis of the North America Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Thermo Fisher Scientific
Alere
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Point-Of-Care Infectious Disease Diagnostics Market
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Based on Types the Market is categorized into Below types that held the largest Point-Of-Care Infectious Disease Diagnostics market share In 2023.
HIV POC
Clostridium Difficile POC
HBV POC
MRSA POC
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-Of-Care Infectious Disease Diagnostics Market Research Analysis
1. Introduction of the North America Point-Of-Care Infectious Disease Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Point-Of-Care Infectious Disease Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Point-Of-Care Infectious Disease Diagnostics Market, By Type
6. North America Point-Of-Care Infectious Disease Diagnostics Market, By Application
7. North America Point-Of-Care Infectious Disease Diagnostics Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Point-Of-Care Infectious Disease Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/